As previously reported, new peptidylnucleoside antibiotics named MRD'sA~D were produced by Streptomyces flavidovirens SANK60486. Their isolation, characterization and structural elucidation revealed their unique physico-chemical properties1'50. In this paper, the biological properties of MRD'sare reported.
Materials and Methods
Antibiotics MRD'swere prepared by Fermentation Research Laboratories, Sankyo Co., Ltd. Fosfomycin (FOM) , cefsulodin (CFS), ceftazidime (CAZ), cefoperazon (CPZ), carbenicillin (CBPC), sulbenicillin (SBPC), piperacillin (PIPC) and cefotaxime (CTX) are commercially available antibiotics. Antimicrobial Activities
For in vitro studies, the strain of P. aeruginosa SANK75775 was grown in Nutrient broth (Eiken) at 37°C with vigorous shaking. In the case of morphological studies, nutrient broth was supplemented with 12% sucrose and 0.1 m MgSO4à"7H2O. MICs were determined by the agar dilution method using Mueller-Hinton agar. Turbidity of the culture was monitored on a Shimadzu Spectronic 20 at absorbance of 550 nm. The bactericidal activity of the antibiotics was measured as follows: 0.1 ml of a logarithmic phase culture of P. aeruginosa SANK75775 was transferred into the test tubes with 9.9 ml of pre-warmed medium containing finally 0, 1, 2, 4 and 8 times MICs of the antibiotics. The tubes were shaken vigorously and aliquots of the culture were withdrew at 1, 2, 4 and 6 hours after inoculation to determine the viable cell numbers after dilution with 0.85 %NaCl. Antibiotic resistant Present address : Technical Licensing Department, Sankyo Co., Ltd., Ginza, Chuo-ku, Tokyo 104, Japan. mutants of P. aeruginosa SANK75775 were selected from the colonies grown on the nutrient agar mediumcontaining antibiotics at 4 times MICs.
In Vivo Experiments
The ddY female mice were infected intravenously with P. aeruginosa SANK75775 grown overnight at 37°C and treated with antibiotics subcutaneously twice at immediately and 4 hours after infection. ED50's were determined on day 7th after infection. For determination of concentrations of MRD's A and C in urine, feces, serum or tissue extract, a paper-disc agar diffusion assay was employed using P. aeruginosa SANK70579 as the test organism.
Results

Antimicrobial
Activity of MRD's MRD'swere active against only few Gram-positive and Gram-negative bacteria tested, except Mueller-Hinton agar. Inoculum size 106 cells/ml. Klebsiella pneumoniae PCI 602 and P. aeruginosa (Table 1 ). MRD's inhibited the growth of P. aeruginosa at the range from <0.1 to 100 /^g/ml.
Amongthem, MRDC was most active and almost all strains of P. aeruginosa were inhibited at concentrations of 3.13^g/ml or less. MRD C's antipseudomonal activity was compared with several /3-lactam antibiotics active against P.
aeruginosa (Table 2) . MRDC was more active than CBPC or SBPC. CTX, PIPC and CPZ showed almost the same activity as MRDC.
It is worth to note that MRDC was not only active against P. aeruginosa SC 8753 which was isolated clinically as /3-lactam-resistant one but also against P. aeruginosa 433, 638, 1008 and 1872 which were fresh clinical isolates.
Emergenceof MRD-resistant P. aeruginosa The spontaneous frequency of acquisition of resistance to MRDC of P. aeruginosa SANK 75775was 1.2xlO"6at MIC and 1.0xl0~6 at 2 and 4 times MICs, respectively. This frequency was similar to that of FOM(5x10"6 at 2 times MICs) but higher than those of CBPC (4.5x10"8 at 4 times MICs) and CTX (5.9x10"8 at 4 times MICs).
To test the cross resistance of MRD'sto^-lactam antibiotics, each antibiotic-resistant mutants were selected at 4 times MICs. As shown in Table 3 , CPZ-resistant (CPZ-1~CPZ-3), CFS-resistant (CFS-1~CFS-3) and CAZ-resistant isolates (CAZ-1 -CAZ-3) were also resistant to each other /3-lactam antibiotics, but MRDC was as active as the parent strain against these resistant bacteria, indicating no cross resistance between MRD'sand /3-lactam antibiotics. Effects of MRDC on the Growth and the Viability of P. aeruginosa To determine the effects of MRDC on the growth of P. aeruginosa SANK75775, cells were grown at 37°C with vigorous shaking in the presence or absence of the antibiotic. As shown in Fig. 1 , at the beginning of incubation, turbidity increased for 2 hours in the presence of MRDC at 1, 2, 4 and 8 times MICs, then it began to decrease rapidly with the cell lysis. The bactericidal activity of MRDC was indicated by a time-dependent decrease in the viable cell number, which, however, slightly increased at 6 hours after inoculation, indicating regrowth of the resistant bacteria even at 8 times MICs (Fig. 2) . MRDC decreased the viable cell number about to 10~4 of the initial, but CBPCdid about only to 10~2, showing that MRDC could kill bacteria in a shorter time than CBPC. Spheroplast formation was detected under the microscope whencells were grown in hypertonic mediumcontaining MRDC (Fig. 3) . These facts point to the inhibition of the cell wall peptidoglycan synthesis3) as the mechanism of action of MRD's.
Toxicity
Mice tolerated a single intravenous injection of MRDA or C at 400 mg/kg without any toxic symptoms for 14 days.
In Vivo Protection Test Mice infected with P. aeruginosa SANK75775 intravenously were treated subcutaneously with MRD's immediately and 4 hours after infection. ED50's of MRD's A~D were determined to be 69, 75, 50 and >100 mg/kg, respectively. Under the same condition, those of CFS and CAZ were 27 and 36 mg/kg, respectively, but CPZ, CBPC, SBPCand PIPC were ineffective even at 400 mg/kg.
Pharmacokinetics in Mice
To investigate the pharmacokinetics of MRD's A and C in mice, they were injected subcutaneously at the dose of 100mg/kg. As shown in Fig. 4 , both antibiotics had concentrations above the MIClevels in serum for about 1 hour. Their half-lives were about 0.7 hour. After subcutaneous administration of MRD'sA and C, the urinary recoveries during 24 hours were 5 %for both and the fecal recoveries were 30 and 18%, respectively. When tissue distribu- Mice were treated with 100 mg/kg of antibiotics subcutaneously and each tissue was removed from sacrificed mice at 0.5, 1 and 24 hours after treatment. The antibiotics were extracted with 50% acetone after homogenization.
ND: Not detected.
tions of MRD'sA and C, given subcutaneously at 100 mg/kg in mice, were measured, levels could be detected only in liver and kidney up to 1 hour, but no activity could be detected in any tissues after 24 hours (Table 4) .
Discussion
It is very interesting to note that MRD'sare selectively active against P. aeruginosa which is known to be generally resistant to many antibiotics, as a consequence of their intrinsic permeability barrier4). Several antibiotics have been found to be active against P. aeruginosa and against many other bacteria, but antibiotics with specific activity against P. aeruginosa have not commonly been found. The biological activities of MRD's can be summarized as follows: They are bactericidal, they induce spheroplast formation of the sensitive bacteria and they cause cell lysis. From these results, the mechanism of action of MRD'sis supposed to be inhibition of peptidoglycan synthesis of the cell wall. In the cell free system for peptidoglycan synthesis, MRDC strongly inhibited the incorporation of 14C-UDP-MurNAc-pentapeptideinto cold TCAinsoluble fractions at a concentration below MIC(data not shown).
It is very important to study the reason why MRD'sare specifically active against P. aeruginosa. The peptidoglycan synthetic machinary of P. aeruginosa may be different from that of other bacteria or their specific permeability system mayallow the influx of MRD'sbut not of other well-known antibiotics5»6).
The ability to decrease the viable cell number in a short period may overcome the potential drawback of rapid emergence of resistant cells, as the immunesystem of the host mayeliminate the small resistant population.
